These specific pathogen cases reflect the heterogenicity of BV and, in some cases, the lack of symptoms in patients, so detection of these proinflammatory biomarkers (IL- 1a, IL-1b, and IP-10) can be a cheap and easy way to identify women at risk of developing STI, to provide an appropriate treatment and help in cervical cancer prevention [42]. This evidence concerns the gene IL1B and bacterial vaginosis.